Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis

BACKGROUND: Oral iron is recommended as first line treatment of anemia in non-dialysis chronic kidney disease (ND-CKD) patients. Sucrosomial® iron, a new generation oral iron with high absorption and bioavailability and a low incidence of side effects, has shown to be not inferior to intravenous (IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccio, Eleonora, Sabbatini, Massimo, Capuano, Ivana, Pellegrino, Angela Maria, Petruzzelli, Luigi Annicchiarico, Pisani, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035732/
https://www.ncbi.nlm.nih.gov/pubmed/32087684
http://dx.doi.org/10.1186/s12882-020-01716-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035732/
https://www.ncbi.nlm.nih.gov/pubmed/32087684
http://dx.doi.org/10.1186/s12882-020-01716-w

Ejemplares similares